Once-daily QVA149 demonstrates superior outcomes in COPD patients previously treated with fixed-dose long-acting beta(2)-agonist/inhaled corticosteroid (LABA/ICS): The ILLUMINATE study
- Resource Type
- Journal
- Source
EUROPEAN RESPIRATORY JOURNAL ; SEP 1 2013, 42 2p. Supplement: 57- Subject
- Language
- English
- ISSN
- 13993003